| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |